ArticleOpen forum infectious diseases2025

Uptake and 24-month Outcomes of Dolutegravir- Versus Lopinavir-based Second-line Antiretroviral Therapy for People With HIV in South Africa: A Retrospective Cohort Study and Emulated Target Trial.

Jennifer Anne Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.